ABSTRACT
La fisura anal es una de las enfermedades más antiguamente descritas, la misma que, ha tenido hasta el momento múltiples tratamientos tanto médicos como quirúrgicos, existiendo controversias en su algoritmo terapéutico. Constituye una de las patologías cuyo diagnóstico y tratamiento corresponde a la Especialidad de Coloproctología, afecta a ambos sexos y a cualquier edad y puede ser aguda o crónica. Proponemos el presente Protocolo para un adecuado manejo de la patología, de manera que sirva de guía en la toma correcta de decisiones basadas en la evidencia y el consenso de quienes integramos la Unidad Técnica de Coloproctología del Hospital de Especialidades Carlos Andrade Marín.
Anal fissure is one of the oldest described diseases, which has so far had multiple medical and surgical treatments, with controversies in its therapeutic algorithm. It is one of the pathologies whose diagnosis and treatment corresponds to the Coloproctology Specialty, it affects both sexes and any age and can be acute or chronic. We propose the present Protocol for an adequate management of the pathology, so that it serves as a guide in the correct decision making based on evidence and consensus of those who integrate the Technical Unit of Coloproctology of the Hospital de Especialidades Carlos Andrade Marín.
Subject(s)
Humans , Male , Adult , Middle Aged , Anal Canal , Anus Diseases , Pruritus Ani , Colorectal Surgery , Fissure in Ano/surgery , Quality of Life , Proctoscopy , Diet , Ecuador , Lateral Internal Sphincterotomy , Hemorrhage , AnalgesiaABSTRACT
O tratamento das doenças anorretais, como a doença hemorroidária e as fissuras anais, é essencialmente clínico para a maioria dos pacientes, estando as alternativas cirúrgicas reservadas para doença avançada. Modificações no estilo de vida são fundamentais na prevenção e no tratamento das doenças anorretais e incluem aumento do consumo de fibras e ingestão de líquidos para evitar a obstipação intestinal, associado a higienização adequada da região anal. Medicamentos tópicos promovem rápido alívio dos sintomas e são amplamente utilizados na prática clínica. A associação do anestésico cinchocaína com o policresuleno, um agente com propriedades pró-coagulantes e vasoconstritoras, promove alívio dos sintomas associados à doença hemorroidária, à fissura anal, ao prurido local e no pós-operatório de cirurgias proctológicas, sendo uma opção terapêutica efetiva e segura para o tratamento conservador das afecções anorretais.
ABSTRACT
Pruritus ani is an unpleasant cutaneous sensation that induces the desire to scratch the skin around the anal orifice. It may start insidiously and appears in 1% to 5% of the population. It is classified as primary (idiopathic) pruritus ani when no cause can be found. However, as 25% to 75% of cases have co-existing pathology, a detailed history and examination are necessary. The goal of treatment is asymptomatic, intact, dry, clean perianal skin with reversal of morphological changes. The management of pruritus ani is directed towards the underlying cause. If the diagnosis is idiopathic pruritus ani, the patients can still be managed with great success by eliminating of irritants and scratching, by giving general advice regarding hygiene and lifestyle modification and by using active treatment measures.
Subject(s)
Humans , Hygiene , Irritants , Life Style , Pruritus , Pruritus Ani , Sensation , SkinABSTRACT
PURPOSE: Idiopathic pruritus ani is a common and embarrassing proctological condition which can be very difficult to treat. In this study, we documented our results with methylene blue intra-dermal injection in patients with intractable idiopathic pruritus ani. METHODS: 5-ml 1% methylene blue, 100-mg hydrocortisone, and 15-ml 1% lidocaine were injected into the perianal skin of 21 patients with idiopathic pruritus ani which had proved refractory to standard care. Clinical follow-up was undertaken. RESULTS: After one injection of the above solution, 15 (71.4%) of the patients were rendered symptom free. Repeat injection in the initial non- responders ultimately rendered another four. 19 (total: 90.5 %) of the patrents symptom free. Morbidity was 0%. CONCLUSION: This study has shown that intra-dermal methylene blue injection is a safe, simple, and efficient method of treating intractable, idiopathic pruritus ani.